Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Quarterly Comparison Figures 2020 (unaudited)

Remedy Entertainment Plc | Company announcement 10:00 (EEST) 5 May 2021 Quarterly Comparison Figures 2020 (unaudited) Remedy will start to release quarterly business reviews in addition to half-year financial reports and annual financial statement releases, as announced in the financial statement release 1 January- 31 December 2020 disclosed 12 February 2021. Business reviews will be released for periods 1 January- 31 March and 1 July- 30 September. The business review for period 1 January- 31 March 2021 will be released on 12 May 2021. Remedy is now releasing comparison figures

Assemblin Norway strengthens its position northwest of Oslo

Assemblin Norway is strengthening its position in the Eastern Norway region (in Viken County) through its acquisition of the heating and sanitation company Hemsedal VVS AS. The firm has 12 employees and annual sales of approximately NOK 35 million.Founded in 2000, Hemsedal VVS AS is a well-established installation company providing water, heating and energy infrastructure to its customers. Hemsedal VVS takes on both contract projects and service assignments, having carved out a specialist niche in the holiday home sector. Its customers include a number of construction firms and cabin

DanCann Pharma A/S have signed a definitive distribution agreement with Tetra Bio-Pharma Inc. for the exclusive distribution of Reduvo™ Adversa® and Qixleef™ in Scandinavia and Germany

COPENHAGEN, Denmark, 5 May 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) is pleased to announce the signing of an agreement with Canadian Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB:TBPMF) (“Tetra”) concerning the exclusive distribution of the cannabinoid-based medicines Reduvo™ Adversa® and Qixleef™ in Denmark, Norway, Sweden, Finland, and Germany.Pursuant to registration with the European Medicines Agency (EMA), DanCann Pharma will handle the exclusive sales and distribution in the Nordics and Germany for the products, Reduvo™ Adversa® and Qixleef™. In addition,

Finnair considers issuance of new notes and announces a voluntary tender offer of its outstanding notes maturing in 2022

Finnair Plc                 Stock Exchange Release             5 May 2021 at 10.00 a.m. EEST NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Finnair Plc (the “Company”) is considering the issuance of new euro-denominated notes (the “New Notes”). The potential issue is expected to take place in the near future subject to market conditions. At

Best Free Bingo Sites

Winning at bingo is even better when it’s free - and losing isn’t so bad all of a sudden, too! The best free bingo sites are the ones that let you get used to playing bingo without having to deposit any real cash yourself.  Free bingo sites, then = absolutely fabulous, zero risk stuff!  On the other hand, the BEST free bingo sites are also a bit tricky to find. For this reason, we’ve done the research for you so that you don’t have to. We’ve uncovered the best sites that offer amazing no deposit welcome bonuses and free play to go along with their fun-filled games and awesome

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

New harvester head for processing eucalyptus trees from Ponsse

Ponsse is launching a new debarking PONSSE H7 HD Euca harvester head alongside the previously released H8 HD Euca. The new powerful harvester head further strengthens Ponsse’s strategy to be the leading global manufacturer of harvester heads.“This new harvester head has been developed together with our customers, based on their feedback. We wanted to introduce an even more powerful and productive harvester head for processing eucalyptus trees that withstands even the most extreme conditions, and we succeeded in this with the H7 HD Euca harvester head”, says Janne Loponen, harvester head

Finnfund invests in Uhuru Growth Fund I to foster growth of West African businesses

Finnfund, a Finnish development financier and impact investor, announce today a USD 10 million commitment to Uhuru Growth Fund I (UGF). UGF is the first generation fund focusing on high growth SME and middle market businesses operating in the consumer-facing and financial services sectors. The fund will seek investments in West African countries including Nigeria, Ghana, Côte d’Ivoire and other Francophone West African markets such as Burkina Faso, Mali and Senegal. Finnfund’s commitment is part of the first close of Uhuru Growth Fund I (UGF) at USD 113 million, announced by Uhuru

Decision by the Disciplinary Committee of Nasdaq Stockholm

The Disciplinary Committee at Nasdaq Stockholm today ordered Swedbank to pay a fine of twelve annual fees, equivalent of SEK 46.6 million. As Swedbank stated in its Q1-report on April 27, the issue concerns historical matters dating back to 2016-2019. The Disciplinary Committee states that Swedbank over a long period of time had shortcomings in its AML processes and routines and that the shortcomings were known to the bank’s former top management for a long period of time.During March, Nasdaq Stockholm AB (Nasdaq) informed the bank of the conclusions of its review as to whether the bank had

Warhammer Age of Sigmar: Soul Arena - a next generation auto battler where forces of good and evil clash to be the last ones standing!

Developer and publisher Trophy Games are very excited to announce Warhammer Age of Sigmar: Soul Arena. Players aim to build the strongest army and be the last person standing in this multiplayer strategy game that takes place in the amazing Warhammer Age of Sigmar universe. This fresh take on the well established auto battler genre will be coming to Android and iOS first, followed by PC later on in the year.Redefining the auto battler genre to its full potential Game speed and optimization are core concepts that have informed the entire design process in creating this next generation

Inhalation Sciences signs IRS contract worth 29 700 EUR with returning established pharma client

(Stockholm 5 May, 2021) Inhalation Research Services (IRS), ISAB’s contract research organization, has signed a new order worth 29.7 KEUR. The order includes key preclinical feasibility evaluations, to be carried out on PreciseInhale[®], and an advanced dissolution and absorption study on DissolvIt[®], ISAB’s leading in vitro tool which delivers exceptionally precise, predictive and life-like data, significantly reducing the risk of clinical failure in later trials.The total value of the order is 29 700 EUR. The contract includes key feasibility and evaluation studies on substances to be

Green energy lowers CO\2\ emissions dramatically

The Lesjöfors companies keep working on their sustainability objectives, where lower CO\2\\ \emissions are one focus area. Velleuer in Germany is a good example of how a transition to a green energy mix can lower emissions by more than half, fast and easy.Ten years ago, the German Lesjöfors company Velleuer certified to the environmental management standard ISO 14001. Since then Velleuer constantly monitors the environmental effects of their output and explores potentials to improve. In 2016, the company succeeded in reversing the negative trend with rising production-related CO\2 \

Balder to acquire asset buyout partners

·Fastighets AB Balder (Balder) has signed an agreement to acquire Norwegian industrial real estate company Asset Buyout Partners (ABP), a portfolio company of HitecVision ·ABP is a leading independent Norwegian industrial real estate company with real estate assets located in mission critical energy and maritime clusters along the Norwegian coast  The deal in briefProperty Value: 9,000 MNOK after deduction of deferred taxNumber of properties: 106 propertiesLettable area and land: 264,000 sqm and 1,781,000 sqm landEconomic occupancy rate: 98 %Average duration of lease

The last day of trading with the warrants of series TO1 in 2cureX AB is today, May 5, 2021

Today, May 5, 2021, is the last day of trading with the warrants of series TO1 in 2cureX AB (“2cureX” or the “Company”). The subscription period for the warrants of series TO1 runs until May 7, 2021. Each warrant of series TO1 gives the owner the right to subscribe for one (1) new share in the Company. The exercise price for the warrants of series TO1 is SEK 13.22 per share.Please note that trading and exercise of warrants of series TO1 that are nominee registered must be conducted in accordance with instructions from each respective nominee. Owners of warrants of series TO1 should contact

ORGANOCLICK AB (PUBL) PUBLISH INTERIM REPORT FOR Q1 2021

"the year started well with very strong sales increase of 33.3 (0.4) percent to MSEK 29.7 (22.2) during the first quarter. The greatest increase took place at the end of the quarter; as this put us beyond our maximum capacity, we have added a third shift of production in April."Translation from CEO Mårten Hellbergs comments to the Interim Report.   Q1, 1 January - 31 March 2021 The Group compared with 2020 » Net revenue amounted to SEK 29.66 (22.25) million » The gross margin (after variable costs) amounted to 42.3 (43.1) % » EBITDA amounted to SEK -0.84 (-1.37) million

Proven radiology capabilities grant Sectra order from Mary Washington Healthcare in the US

Linköping, Sweden and Shelton, CT – May 5, 2021 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) will provide its enterprise imaging solution to Mary Washington Healthcare. They will utilize the platform’s radiology and breast imaging modules as well as the enterprise archive (VNA) to store all radiology images, including cardiology images, throughout the organization. This unified imaging approach will provide all caregivers a full patient overview regardless of their reading location and facilitate collaboration with their contracted

SynAct Pharma: Interim report January-March 2021

“The first three months have indeed given a strong and convincing start of the new year to SynAct Pharma, when we continued to make significant progress on our projects and put the company in a unique position to be a leader in resolution therapy, a new method for treating inflammation and autoimmune diseases,” said Jeppe Øvlesen, CEOSummary of interim report 2021-01-01 – 2021-03-31 (first quarter) · Consolidated net sales amounted to 0 (0) TSEK. · The Group's profit before tax amounted to -14,070 ( -3,822) TSEK. · The Group's earnings per share amounted to -0.46 (-0.14). ·

Vestas – Interim Financial Report, First Quarter 2021

Vestas Wind Systems A/S, Aarhus, 5 May 2021Company announcement no. 10/2021   Summary: Revenue and EBIT decreased compared to same quarter 2020. Record high combined order backlog as a consequence of the integration of offshore. Full-year guidance maintained. In the first quarter of 2021, Vestas generated revenue of EUR 1,962m – a decrease of 12 percent compared to the year-earlier period. EBIT before special items decreased by EUR 17m to EUR (71)m. This resulted in an EBIT margin before special items of (3.6) percent, compared to (2.4) percent in the first quarter of 2020. Free

Peikko Group recruits 50 new professionals to Sales and Engineering

Peikko Group will recruit 50 new talents for sales and engineering positions during Q2-Q3 of 2021. The new positions will be located in a total of 23 countries: Australia, Belgium, China, Czech Republic, Denmark, Estonia, Finland, France, Germany, Italy, Korea, Latvia, Malaysia, the Netherlands, Poland, Romania, Russia, Singapore, Slovakia, Spain, Switzerland, Turkey, and the United Kingdom. Peikko is looking for local talents to provide its customers an even better and quicker service. Applicants will need to speak the local language and know the local construction culture.

Ilari Hyyrynen appointed as Managing Director of Sibylla Russia

Company announcement, 5 May 2021, 9 am.Ilari Hyyrynen appointed as Managing Director of Sibylla RussiaFollowing the sale of Atria’s Russian subsidiary Pit Product, Ilari Hyyrynen (MBA) has been appointed Managing Director of Sibylla Russia, a fast food chain operating in Russia, Kazakhstan and Belarus, as of 5 May 2021. Ilari Hyyrynen has previously worked as Executive Vice President of Atria Russia business area.Ilari Hyyrynen is a member of Atria Group's Management Team and reports to CEO Juha Gröhn.For additional information, please contact Mr Juha Gröhn, CEO, tel. +358 400 684

Catena Media explores refinancing of existing bonds

Catena Media plc’s current debt financing consists of a senior secured bond loan, ISIN SE0010832154, with a total outstanding nominal amount of EUR 88.5 million and maturity in March 2022. To maintain a prudent maturity profile, Catena Media will explore different refinancing alternatives to replace the existing bond loan. This includes the procurement of bank loans as well as mandating Carnegie Investment Bank to arrange investor meetings to investigate the possibility of issuing a new bond loan, subject to market conditions.   For further information, please contact:   Michael

Alligator’s mitazalimab shown to enhance cancer vaccine

Lund, Sweden, May 5, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that preclinical data on its agonist anti-CD40 antibody mitazalimab has been published in the scientific journal Cancer Immunology, Immunotherapy.The published data show that mitazalimab activates dendritic cells and tumor-reactive T cells resulting in enhanced anti-tumor efficacy in combination with a model cancer vaccine. Title: The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells and enhances

Interim Report First Quarter 2021

Yet Another Quarter with Record High Revenues and EbitdaFIRST QUARTER · Revenues increased 42.6% to €48.1 million (33.7). · EBITDA increased 64.2% to €8.6 million (5.2). · The EBITDA margin increased to 17.8% (15.5%). · EBIT increased 66.3% to €6.5 million (3.9). · Earnings after tax increased 140% to €6.1 million (2.5). · Earnings per share, basic and diluted, increased 160% to €0.13 (0.05). SIGNIFICANT EVENTS IN THE QUARTER AND AFTER THE END OF THE QUARTER · Revenues increased 42.6% from Q1 2020 driven by strong development in all segments and the acquisition

There are no items matching the current filter
There are no more items matching the current filter
Back to top